Allogene Therapeutics Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Veer Bhavnagri | 3 | -11,602 |
Geoffrey M. Parker | 1 | 190 |
Deborah M. Messemer | 1 | -18,640 |
Stephen Mayo | 1 | -10,000 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 190 | 0 | 190 |
最近6个月 | 190 | 18,640 | -18,450 |
最近12个月 | 190 | 28,640 | -28,450 |
最近18个月 | 190 | 40,242 | -40,052 |
最近36个月 | 190 | 72,242 | -72,052 |
Allogene Therapeutics Inc 内部交易
Allogene Therapeutics Inc 最新内部交易
Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | 2024-01-30 | 买入 | 190 | 819,590 |
$3.6
|
-19.72%
|
Deborah M. Messemer | 董事 | 2023-12-18 | 卖出 | 18,640 | 62,456 |
$2.7
|
+7.04%
|
Stephen Mayo | 董事 | 2023-08-07 | 卖出 | 10,000 | 25,328 |
$4.29
|
-32.63%
|
Veer Bhavnagri | General Counsel | 2023-02-13 | 卖出 | 3,000 | 577,677 |
$6.85
|
-57.81%
|
Veer Bhavnagri | General Counsel | 2023-01-17 | 卖出 | 3,000 | 580,677 |
$7.04
|
-58.95%
|
Veer Bhavnagri | General Counsel | 2022-12-15 | 卖出 | 5,602 | 583,677 |
$7.53
|
-61.62%
|
Owen N. Witte | 董事 | 2022-08-12 | 卖出 | 15,000 | 218,271 |
$16.75
|
-82.75%
|
Owen N. Witte | 董事 | 2022-08-12 | 卖出 | 15,000 | 218,271 |
$16.75
|
-82.75%
|
Rafael Amado | EVP of R&D & CMO | 2022-08-02 | 卖出 | 2,000 | 540,257 |
$11.97
|
-75.86%
|
Rafael Amado | EVP of R&D & CMO | 2022-07-05 | 卖出 | 2,000 | 542,257 |
$11.44
|
-74.74%
|